Autophagy in dendritic cells helps anticancer activity

Autophagy in dendritic cells helps anticancer activity
Figure 1.Mechanism of autophagy in dendritic cells. Credit: The Korea Advanced Institute of Science and Technology (KAIST)

Autophagy contributes to the homeostasis of a cell and recently another function of autophagy has been reported. A KAIST research team found that the autophagy of dendritic cells supports T-cell anticancer activity.

Autophagy is a process of maintaining cell homeostasis by removing cellular waste and damaged cellular organelles; nevertheless, its role in the presentation of phagocytized tumor-associated antigens remains vague.

Meanwhile, dendritic cells are the ones that recognize pathogens or cancer antigens, and induce immune responses in T cells. When are killed by radiation or an anticancer drug, dendritic cells absorb and remove them and present antigens on their surface to transfer them to T-cells.

Professor Heung Kyu Lee from the Graduate School of Medical Science and Engineering and his team found that the autophagy of dendritic cells plays a key role in T-cell activation and they proposed the principles of enhancing anti-cancer effects.

Their experiments showed that T-cell activation of dendritic cells as well as anticancer dropped when there is a deficiency of Atg5 (autophagy-related) in dendritic cells.

Interestingly, Atg5-deficient significantly elevated receptor CD36 on the surface of the cells, which increased the phagocytosis of apoptotic tumor cells yet restricted the activation of T-cells.

Autophagy in dendritic cells helps anticancer activity
Figure 2. A role of autophagy in dendritic cells. Credit: The Korea Advanced Institute of Science and Technology (KAIST)

At this time, when introducing antibodies into the system in order to block the receptor CD36, the anti-tumor T-cell response increased substantially while tumor growth declined.

Professor Lee said, "This study allowed us to explore the role of autophagy in the anti-cancer immune response of T-cells. We look forward to developing targeted anti-cancer therapies using the receptor CD36."

This research was published in Autophagy.


Explore further

Cellular self-digestion process triggers autoimmune disease

More information: Dong Sun Oh et al. Autophagy protein ATG5 regulates CD36 expression and anti-tumor MHC class II antigen presentation in dendritic cells, Autophagy (2019). DOI: 10.1080/15548627.2019.1596493
Citation: Autophagy in dendritic cells helps anticancer activity (2019, May 13) retrieved 23 August 2019 from https://medicalxpress.com/news/2019-05-autophagy-dendritic-cells-anticancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more